These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10561281)

  • 1. Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin.
    Herman EH; Zhang J; Lipshultz SE; Rifai N; Chadwick D; Takeda K; Yu ZX; Ferrans VJ
    J Clin Oncol; 1999 Jul; 17(7):2237-43. PubMed ID: 10561281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of cardiac troponin T levels as an indicator of doxorubicin-induced cardiotoxicity.
    Herman EH; Lipshultz SE; Rifai N; Zhang J; Papoian T; Yu ZX; Takeda K; Ferrans VJ
    Cancer Res; 1998 Jan; 58(2):195-7. PubMed ID: 9443390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicity.
    Herman EH; Zhang J; Rifai N; Lipshultz SE; Hasinoff BB; Chadwick DP; Knapton A; Chai J; Ferrans VJ
    Cancer Chemother Pharmacol; 2001 Oct; 48(4):297-304. PubMed ID: 11710630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-related differences in mast cell activity and doxorubicin toxicity: a study in spontaneously hypertensive rats.
    Zhang J; Knapton A; Lipshultz SE; Cochran TR; Hiraragi H; Herman EH
    Toxicol Pathol; 2014; 42(2):361-75. PubMed ID: 23531790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum cardiac troponin T as a biomarker for acute myocardial injury induced by low doses of isoproterenol in rats.
    Herman E; Zhang J; Knapton A; Lipshultz SE; Rifai N; Sistare F
    Cardiovasc Toxicol; 2006; 6(3-4):211-22. PubMed ID: 17347531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum troponin T levels and echocardiographic evaluation in children treated with doxorubicin.
    Kismet E; Varan A; Ayabakan C; Alehan D; Portakal O; Büyükpamukçu M
    Pediatr Blood Cancer; 2004 Mar; 42(3):220-4. PubMed ID: 14752858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo examination of cardiac troponins as biochemical markers of drug-induced cardiotoxicity.
    Adamcová M; Šimůnek T; Kaiserová H; Popelová O; Štěrba M; Potáčová A; Vávrová J; Maláková J; Geršl V
    Toxicology; 2007 Jul; 237(1-3):218-228. PubMed ID: 17587482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential cardiotoxicity in response to chronic doxorubicin treatment in male spontaneous hypertension-heart failure (SHHF), spontaneously hypertensive (SHR), and Wistar Kyoto (WKY) rats.
    Sharkey LC; Radin MJ; Heller L; Rogers LK; Tobias A; Matise I; Wang Q; Apple FS; McCune SA
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):47-57. PubMed ID: 23993975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the severity of the chronic cardiotoxicity produced by doxorubicin in normotensive and hypertensive rats.
    Herman EH; el-Hage AN; Ferrans VJ; Ardalan B
    Toxicol Appl Pharmacol; 1985 Apr; 78(2):202-14. PubMed ID: 4035676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of cardiac troponin I and T levels as markers of myocardial damage in doxorubicin-induced cardiomyopathy rats, and their relationship with echocardiographic and histological findings.
    Bertinchant JP; Polge A; Juan JM; Oliva-Lauraire MC; Giuliani I; Marty-Double C; Burdy JY; Fabbro-Peray P; Laprade M; Bali JP; Granier C; de la Coussaye JE; Dauzat M
    Clin Chim Acta; 2003 Mar; 329(1-2):39-51. PubMed ID: 12589964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response relationship of dexrazoxane for prevention of doxorubicin-induced cardiotoxicity in mice, rats, and dogs.
    Imondi AR; Della Torre P; Mazué G; Sullivan TM; Robbins TL; Hagerman LM; Podestà A; Pinciroli G
    Cancer Res; 1996 Sep; 56(18):4200-4. PubMed ID: 8797592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-course study on doxorubicin-induced nephropathy and cardiomyopathy in male and female LOU/M/Wsl rats: lack of evidence for a causal relationship.
    van Hoesel QG; Steerenberg PA; Dormans JA; de Jong WH; de Wildt DJ; Vos JG
    J Natl Cancer Inst; 1986 Feb; 76(2):299-307. PubMed ID: 3456068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between extent of myocardial fibrosis assessed by cardiac magnetic resonance and cardiac troponin T release in patients with nonischemic heart failure.
    Takashio S; Yamamuro M; Uemura T; Utsunomiya D; Morita K; Izumiya Y; Sugiyama S; Kojima S; Yamamoto E; Tsujita K; Tanaka T; Tayama S; Kaikita K; Hokimoto S; Yasuda O; Yamashita Y; Ogawa H
    Am J Cardiol; 2014 May; 113(10):1697-704. PubMed ID: 24698466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cardiac troponin I and T, including the evaluation of an ultrasensitive assay, as indicators of doxorubicin-induced cardiotoxicity.
    Reagan WJ; York M; Berridge B; Schultze E; Walker D; Pettit S
    Toxicol Pathol; 2013; 41(8):1146-58. PubMed ID: 23531791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of advanced glycation end-products, pentosidine and N(epsilon)-(carboxymethyl)lysine, in doxorubicin-induced cardiomyopathy in rats.
    Moriyama T; Kemi M; Okumura C; Yoshihara K; Horie T
    Toxicology; 2010 Jan; 268(1-2):89-97. PubMed ID: 20004697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma levels of troponin T in rabbits after administration of new antineoplastic agents (Oracin and Dimefluron) and daunorubicin].
    Adamcová M; Machácková J; Gersl V; Hrdina R; Mazurová Y; Mĕlka M; Nobilis M
    Acta Medica (Hradec Kralove) Suppl; 2001; 44(1):3-8. PubMed ID: 11892362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac troponin T as a marker of myocardial damage caused by antineoplastic drugs in rabbits.
    Adamcová M; Gersl V; Hrdina R; Melka M; Mazurová Y; Vávrová J; Palicka V; Kokstein Z
    J Cancer Res Clin Oncol; 1999; 125(5):268-74. PubMed ID: 10359131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Effects of Liraglutide, Oxytocin and Granulocyte Colony-Stimulating Factor in Doxorubicin-Induced Cardiomyopathy Model: An Experimental Animal Study.
    Taşkıran E; Erdoğan MA; Yiğittürk G; Erbaş O
    Cardiovasc Toxicol; 2019 Dec; 19(6):510-517. PubMed ID: 31054117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoproterenol-induced cardiotoxicity in sprague-dawley rats: correlation of reversible and irreversible myocardial injury with release of cardiac troponin T and roles of iNOS in myocardial injury.
    Zhang J; Knapton A; Lipshultz SE; Weaver JL; Herman EH
    Toxicol Pathol; 2008 Feb; 36(2):277-8. PubMed ID: 18349426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of combination of cardiac magnetic resonance imaging and high-sensitivity cardiac troponin T assay in diagnosis of inflammatory cardiomyopathy.
    Šramko M; Kubánek M; Tintěra J; Kautznerová D; Weichet J; Malušková J; Franeková J; Kautzner J
    Am J Cardiol; 2013 Jan; 111(2):258-64. PubMed ID: 23102878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.